Pieter Depuydt

12PUBLICATIONS
114CO-AUTHORS
HaematologyCardiology (incl. cardiovascular diseases)Medical infection agents (incl. prions)Respiratory diseasesInformation systems development methodologies and practice
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 14, 2026
ExtracorporeaL life support and Modification Of Hemostasis: the ELMOH trial: hemostatic changes during the first 48 h of VV- and VA-ECMO: a prospective multicenter cohort study.

|Aug 23, 2023
A complement atlas identifies interleukin-6-dependent alternative pathway dysregulation as a key druggable feature of COVID-19.

Karel F A Van Damme, Levi Hoste, Jozefien Declercq

|Apr 29, 2023
Pathogen-based target attainment of optimized continuous infusion dosing regimens of piperacillin-tazobactam and meropenem in surgical ICU patients: a prospective single center observational study.

Thomas De Corte, Jarne Verhaeghe, Sofie Dhaese

|Oct 28, 2021
Antimicrobial prescription in severe COVID-19 and CAP: a matched case-control study.

J Fierens, L De Bus, K Colpaert

|Jun 23, 2021
Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis.

Paul E Verweij, Roger J M Brüggemann, Elie Azoulay

|May 29, 2021
Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trial.

Lore Vanderbeke, Nico A F Janssen, Dennis C J J Bergmans

Pageof 2

Frequent Collaborators

4 joint publications

Liesbet De Bus

4 joint publications

Jeroen Schouten

3 joint publications

Bart J A Rijnders

3 joint publications

Paul E Verweij